Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I

M Sokolowska, GE Rovati, Z Diamant, E Untersmayr… - Allergy, 2021 - Wiley Online Library
Eicosanoids are biologically active lipid mediators, comprising prostaglandins, leukotrienes,
thromboxanes, and lipoxins, involved in several pathophysiological processes relevant to …

G protein-coupled receptor (GPCR) pharmacogenomics

MD Thompson, D Reiner-Link, A Berghella… - Critical Reviews in …, 2024 - Taylor & Francis
The field of pharmacogenetics, the investigation of the influence of one or more sequence
variants on drug response phenotypes, is a special case of pharmacogenomics, a discipline …

Genetic variants of the arachidonic acid pathway in non‐steroidal anti‐inflammatory drug‐induced acute urticaria

JA Cornejo‐García, LR Jagemann… - Clinical & …, 2012 - Wiley Online Library
Background To date, genetic studies of hypersensitivity reactions to non‐steroidal anti‐
inflammatory drugs (NSAID s) have been carried out mainly in aspirin‐induced asthma and …

Role of prostaglandin D2 and its receptors in the pathophysiology of asthma

T Oguma, K Asano, A Ishizaka - Allergology International, 2008 - jstage.jst.go.jp
ABSTRACT Prostaglandin D2 (PGD2) is one of the most abundant lipid mediators present in
the airways of asthmatics. However, little was known of the role it plays in the …

PTGDR gene in asthma: a functional, genetic, and epigenetic study

M Isidoro‐García, C Sanz, V García‐Solaesa… - Allergy, 2011 - Wiley Online Library
To cite this article: Isidoro‐García M, Sanz C, García‐Solaesa V, Pascual M, Pescador DB,
Lorente F, Dávila I. PTGDR gene in asthma: a functional, genetic, and epigenetic study …

Pharmacogenetics of the G protein-coupled receptors

MD Thompson, DEC Cole, V Capra… - … in Drug Discovery and …, 2014 - Springer
Pharmacogenetics investigates the influence of genetic variants on physiological
phenotypes related to drug response and disease, while pharmacogenomics takes a …

Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis

G Philip, J van Adelsberg, T Loeys, N Liu… - Journal of allergy and …, 2009 - Elsevier
BACKGROUND: Prostaglandin D2 is a proinflammatory mediator believed to be important in
asthma and allergic rhinitis (AR). Allelic variants in the prostaglandin D2 receptor type 1 …

[PDF][PDF] Genetic association study in nasal polyposis

DB Pescador, M Isidoro-Garcia… - J Investig Allergol …, 2012 - esmonformacion.com
■ Abstract Background and Objectives: Nasal polyposis (NP) is a chronic inflammatory
disease of the upper airways with a variable clinical course and unknown pathogenesis that …

Molecular analysis of IL-5 receptor subunit alpha as a possible pharmacogenetic biomarker in asthma

S Elena-Pérez, DH Heredero-Jung… - Frontiers in …, 2021 - frontiersin.org
Background: Asthma is a heterogeneous syndrome with a broad clinical spectrum and high
drug response variability. The inflammatory response in asthma involves multiple effector …

(CCTTT) n polymorphism of NOS2A in nasal polyposis and asthma: a case-control study.

M Pascual, CS Sanz Lozano… - … allergology & clinical …, 2008 - gredos.usal.es
[EN] Nitric Oxide (NO) has been proposed as an important signaling molecule. NO produced
by the inducible NO synthase enzyme NOS2A is generated at high levels in certain types of …